Hemodynamical Evaluation of a New Surgically Implanted Pulsatile Right Ventricular Assist Device Driven by a Conventional Intra-Aortic Balloon Pump Console.

Severe right heart failure, often overlooked and challenging to manage, has prompted a growing interest in innovative approaches to provide functional support. This study uses experimentation in large porcine models to introduce a novel prototype of a pulsatile mechanical circulatory support device and document its effects when deployed as a right ventricular assist device (RVAD). The pulsatile ventricular assist platform (pVAP), featuring a membrane pump driven by an intra-aortic balloon pump console, actively generates pulsatile flow to propel right ventricular blood into the pulmonary artery. This novel prototype demonstrates promising potential in addressing the challenges of right heart failure management. After preliminary in vitro assessments, the pVAP was tested on seven porcine models in a healthy state and after the induction of right ventricular failure. During the procedure, a set of standard (ie, standard-of-care) hemodynamic measurements was obtained. Additionally, invasive pressure-volume loop analysis was employed to examine left ventricular hemodynamics. Results indicated that activation of the pVAP during right ventricular failure significantly improved systemic hemodynamics and enhanced left ventricular function. This study sheds light on the potential of the pVAP in managing right heart failure.

Continuous monitoring of central venous oxygen saturation in neonates and small infants: in vitro evaluation of two different oximetry catheters.

BACKGROUND: Accurate assessment and monitoring of the cardiocirculatory function are essential during major pediatric and pediatric cardiac surgery. Monitoring of the central venous oxygen saturation (ScvO(2)) may be a better indicator of tissue oxygenation and derangement of cellular oxygen utilization than the more commonly used vital parameters. Therefore, we compared oxygen saturation measurements with thin fiberoptic oximetry catheters and standard blood gas oximetry in an in vitro setting. METHODS: Two different size continuous fiberoptic oximetry catheters (2-4-F) were inserted in an extracorporeal circuit filled with human red blood cells in normal saline (haematocrit 30%, flow 600 ml.min(-1)). The results of fiberoptic oximetry were then compared with standard blood gas oximetry for a wide range of different oxygen saturations using linear regression. RESULTS: The oxygen saturations found ranged from 9% to 100%. The results of the two different fiberoptic oximetry catheters correlated significantly (r = 0.99, P < 0.0001) with standard blood gas oximetry. CONCLUSION: The results of fiberoptic oximetry are nearly identical with standard blood gas oximetry for a wide range of different oxygen saturations. Thin oximetry catheters can be inserted percutaneously even in neonates and small infants. The continuous monitoring of ScvO(2) may be beneficial, especially in patients who are in danger of developing low cardiac output or sudden cardiovascular collapse.